UZ Gent ( Site 1002)
Gent, Oost-Vlaanderen, Belgium
University hospital in Ghent
Corneel Heymanslaan 10, 9000 Gent
About UZ Gent ( Site 1002)
Ghent University Hospital is one of the largest hospitals in Belgium. It is closely linked to Ghent University, the university's rector also being the hospital's president. Both the university and the hospital are autonomous entities of the Flemish Government.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at UZ Gent ( Site 1002)
During the past decade, UZ Gent ( Site 1002) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-10-01
2013-04-01
Completed
460
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients
2001-04-04
2037-12-01
Active, not recruiting
232
Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer
2001-08-01
2002-06-01
Completed
5
The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)
2005-05-01
2008-06-01
Completed
250
Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
2003-11-01
2004-10-01
Completed
63
Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
2004-06-08
2017-12-19
Completed
270
Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
2004-06-01
2006-02-01
Completed
74
Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer
2005-05-01
2011-04-01
Completed
13
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UZ Gent ( Site 1002)"
#1 collaborator was "Eisai Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at UZ Gent ( Site 1002)
According to Clinical.Site data, the most researched conditions in "UZ Gent ( Site 1002)" are
"Advanced/Metastatic Gastroesophageal Adenocarcinoma" (1 trials) and "Invasive Aspergillosis" (1 trials). Many other conditions were trialed in "UZ Gent ( Site 1002)" in a lesser frequency.
Clinical Trials Intervention Types at UZ Gent ( Site 1002)
Most popular intervention types in "UZ Gent ( Site 1002)" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "5-FU" (1 trials), "Capecitabine" (1 trials), "Lenvatinib" (1 trials), "Leucovorin (or Levoleucovorin)" (1 trials) and "Oxaliplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UZ Gent ( Site 1002)
The vast majority of trials in "UZ Gent ( Site 1002)" are
2 trials for "All" genders.
Clinical Trials Status at UZ Gent ( Site 1002)
Currently, there are NaN active trials in "UZ Gent ( Site 1002)".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in UZ Gent ( Site 1002),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UZ Gent ( Site 1002), 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".